Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SoloSTAR vs Syringe Glargine in Discharged Diabetic Patients
NCT01203774Phase 4Completed
- Sponsor
- University of Colorado Denver
- Start
- Sep 2010
- Primary completion
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in diabetes mellitus type 1 (T1D), type 2 diabetes mellitus (T2DM), sponsored by University of Colorado Denver. Started Sep 2010; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01203774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01203774.